CMR’s Versius in use for under-18s surgical operations

CMR Surgical has begun the first multicentre prospective clinical trial to assess the safety and efficacy of its Versius robot for use in paediatric surgery.

The trial is focusing on children and infants under the age of 18, undergoing a range of urological procedures with Versius including but not limited to robotic-assisted pyeloplasty, ureteroureterostomy, nephrectomy and Mitrofanoff formation.

The Versius Surgical Robotic System is a small, modular and versatile surgical robot used for minimal access surgery – a form of keyhole surgery. The uniquely small and modular design gives the surgeon optimal access in small, hard-to-reach spaces within an operating zone, while maintaining clear access to the patient for the anaesthetist and wider surgical team. Versius’ design provides the opportunity to support surgeons to conduct robotic-assisted paediatric surgery, and bring the benefits to more patients.

Mark Slack, co-founder and chief medical officer at CMR Surgical, said: “We are delighted to begin the world’s first paediatric trials using Versius, in the UK. We are committed to the responsible introduction of Versius across new specialties and we look forward to working with our partners as we undertake this clinical trial to ensure the safety and efficacy of Versius in paediatrics.”